نتایج جستجو برای: hpv vaccine

تعداد نتایج: 124304  

Journal: :Vaccine 2013
Laura A V Marlow Gregory D Zimet Kirsten J McCaffery Remo Ostini Jo Waller

Since vaccination against human papillomavirus (HPV) became available, awareness of HPV has dramatically increased. Implementation of a vaccine program varies internationally yet no studies have explored the influence this has on the public's knowledge of HPV. The present study aimed to explore differences in awareness of HPV and HPV knowledge across three countries: The US, UK and Australia. P...

Journal: :Clinical journal of oncology nursing 2006
Monica R McLemore

In 2006, the U.S. Food and Drug Administration (FDA) approved the first vaccine for prevention of cervical cancer based on the molecular biology of the disease. Gardasil (quadrivalent human papillomavirus [HPV] [types 6, 11, 16, and 18] recombinant vaccine, Merck & Co., Inc., Whitehouse Station, NJ) combats the common types of HPV responsible for cervical cancer precursor lesions. This article ...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2011
Phanida Juntasopeepun Patricia M Davidson Natthawan Suwan Yupin Phianmongkhol Jatupol Srisomboon

AIMS The aims of this study were to examine knowledge and beliefs regarding HPV and cervical cancer and to predict HPV vaccination intention among young women in Thailand using a cross-sectional descriptive study design. METHODS An online survey was carried out to obtain young women's demographic, HPV and cervical cancer-related health characteristics, knowledge, and beliefs toward HPV and ce...

Journal: :Australian family physician 2009
Stella Heley Julia Brotherton

BACKGROUND Worldwide, cervical cancer affects 500 000 women and causes 275 000 deaths annually. Persistent infection with one of 13 oncogenic types of human papillomavirus (HPV) is now known to be the cause of both squamous and adenocervical carcinomas of the cervix. The Pap test involves the examination of exfoliated cells from the cervix and has been shown to be an effective way of detecting ...

Journal: :Journal of the American Board of Family Medicine : JABFM 2010
Heide B Schneider

OBJECTIVES The objective of this study was to determine factors that influence parent's acceptance of a mandatory school-based human papillomavirus (HPV) vaccination program. METHODS A convenience sample of 325 parents, with children aged 9 to 17 years old, completed a 53-item survey. Survey questions targeted their opinions about HPV, the HPV vaccine, and a mandatory HPV vaccination program....

2011
Karly P. Garnock-Jones Anna R. Giuliano

The quadrivalent HPV types 6, 11, 16, 18 vaccine (Gardasil®) is a recombinant vaccine comprising purified virus-like particles derived from the L1 capsid proteins of HPV types 6, 11, 16 and 18. The vaccine was highly immunogenic. Geometric mean titres (GMTs) and seroconversion rates for all four HPV types at month 7 in males aged 10-15 years were noninferior to those in females aged 16-23 years...

Journal: :Journal of pediatric and adolescent gynecology 2008
Rita M Bair Rose M Mays Lynne A Sturm Gregory D Zimet

STUDY OBJECTIVE To describe Latina mothers' acceptance of the human papillomavirus (HPV) vaccine for their daughters and explore their knowledge base regarding HPV-related issues. DESIGN Individual interviews were conducted with a convenience sample of 40 Latina mothers of daughters 7-14 years old, from an urban, pediatric primary care clinic. Preliminary questions were asked regarding HPV kn...

Journal: :Vaccine 2006
Luisa L Villa Kevin A Ault Anna R Giuliano Ronaldo L R Costa Carlos A Petta Rosires P Andrade Darron R Brown Alex Ferenczy Diane M Harper Laura A Koutsky Robert J Kurman Matti Lehtinen Christian Malm Sven-Eric Olsson Brigitte M Ronnett Finn Egil Skjeldestad Margareta Steinwall Mark H Stoler Cosette M Wheeler Frank J Taddeo Jimmy Yu Lisa Lupinacci Radha Railkar Rocio Marchese Mark T Esser Janine Bryan Kathrin U Jansen Heather L Sings Gretchen M Tamms Alfred J Saah Eliav Barr

Human papillomavirus (HPV) infection causes cervical cancer and genital warts. Young women (1106) were randomized to receive one of three formulations of a quadrivalent HPV (Types 6/11/16/18) L1 virus-like particle (VLP) vaccine or one of two placebo formulations. The goal was to assess vaccine safety and immunogenicity in baseline HPV 6/11/16 or 18-naïve and previously infected subjects. All t...

Hessam Mirshahabi Hoorieh Soleimajjahi, Mahmoud Mahmoudi Maryam Kheirandish Mojtaba Meshkat Zahra Meshkat Zuhair Mohammad Hassan

Background: Cervical cancer is the most prevalent tumor in developing countries and the second most frequent cancer among female population worldwide. Specific human papillomaviruses and, most notably, HPV types 16 and 18 are recognized as being caus-ally associated with cervical carcinomas. The early HPV type 16 genes, E6 and E7, di-rectly participate in the in vitro transformation of primary ...

2011
Aimée R. Kreimer Ana Cecilia Rodriguez Allan Hildesheim Rolando Herrero Carolina Porras Mark Schiffman Paula González Diane Solomon Silvia Jiménez John T. Schiller Douglas R. Lowy Wim Quint Mark E. Sherman John Schussler Sholom Wacholder

BACKGROUND Three-dose regimens for human papillomavirus (HPV) vaccines are expensive and difficult to complete, especially in settings where the need for cervical cancer prevention is greatest. METHODS We evaluated the vaccine efficacy of fewer than three doses of the HPV16/18 vaccine Cervarix in our Costa Rica Vaccine Trial. Women were randomly assigned to receive three doses of the HPV16/18...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید